Absence of gender disparity in short-term clinical outcomes in patients with acute ST-segment elevation myocardial infarction undergoing sirolimus-eluting stent based primary coronary intervention: A report from Shanghai acute coronary event (SACE) registry

Chinese Medical Journal

Volumn 123, Issue 7, 2010, Pages 782-788

  Zhang, Qi ^a   Qiu, Jian Ping ^b   Zhang, Rui Yan ^a   Li, Yi Gang ^a   He, Ben ^c   Jin, Hui Gen ^d   Zhang, Jun Feng ^a   Wang, Xiao Long ^d   Jiang, Li ^e   Liao, Min Lei ^f   Hu, Jian ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Pudong New Area Gongli Hospital   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^e Shanghai Changning Center Hospital   (China)

^f Baoshan Central Hospital   (China)

Author keywords

Acute myocardial infarction; Angioplasty; Gender; Prognosis; Stent

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; RAPAMYCIN;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CHINA; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-BACTERIAL AGENTS; CHINA; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGISTRIES; SEX FACTORS; SIROLIMUS;

EID: 77950909226     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.07.004     Document Type: Article

References (44)

1. Price JF, Fowkes FG. Risk factors and the sex differential in coronary artery disease. Epidemiology 1997; 8: 584-591.
2. Mak KH, Kark JD, Chia KS, Sim LL, Foong BH, Ding ZP, et al. Ethnic variations in female vulnerability after an acute coronary event. Heart 2004; 90: 621-626.
3. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999; 99: 1165-1172.
4. Campbell DJ. Why do men and women differ in their risk of myocardial infarction? Eur Heart J 2008; 29: 835-836.
5. Srinivas VS, Garg S, Negassa A, Bang JY, Monrad ES. Persistent sex difference in hospital outcome following percutaneous coronary intervention: results from the New York State reporting system. J Invasive Cardiol 2007; 19:265-268.
6. Vaccarino V, Krumholz HM, Yarzebski J, Gore JM, Goldberg RJ. Sex differences in 2-year mortality after hospital dischargefor myocardial infarction. Ann Intern Med 2001; 134:173-181.
7. Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation 1995; 91: 1861-1871.
8. Kanamasa K, Ishikawa K, Hayashi T, Hoshida S, Yamada Y, Kawarabayashi T, et al. Increased cardiac mortality in women compared with men in patients with acute myocardial infarction. Intern Med 2004; 43: 911-918.
9. Milcent C, Dormont B, Durand-Zaleski I, Steg PG. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database. Circulation 2007; 115: 833-839.
10. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
11. Singh KP, Harrington RA. Primary percutaneous coronary intervention in acute myocardial infarction. Med Clin North Am 2007; 91: 639-655.
12. Zhang Q, Zhang RY, Qiu JP, Jin HG, Zhang JF, Wang XL, et al. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study. Chin Med J 2009; 122: 636-642.
13. Menichelli M, Parma A, Pucci E, Fiorilli R, De Felice F, Nazzaro M, et al. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol 2007; 49: 1924-1930.
14. Shen WF. Interventional therapy of coronary artery disease in China: retrospective and perspective. Chin Med J 2008; 121:2336-2341.
15. Lee KH, Jeong MH, Ahn YK, Kim JH, Chae SC, Kim YJ, et al. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 2008; 130:227-234.
16. Peixoto RT, Peixoto EC, Sena MA, Tedeschi AL, Borges IP, Rachid MB. Gender influence on the immediate and medium-term progression after primary percutaneous coronary intervention and analysis of independent risk factors for death or events. Arq Bras Cardiol 2006; 86: 211-218.
17. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008; 51:210-247.
18. Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. J Am Coll Cardiol 2003; 42: 7-16.
19. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115:2344-2351.
20. Rao SV, O'Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW, et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 2006; 47: 809-816.
21. Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, et al. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis 2008; 19: 271-277.
22. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113: e166-e286.
23. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341: 217-225.
24. Vakili BA, Kaplan RC, Brown DL. Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction. Circulation 2001; 104:3034-3038.
25. Mehilli J, Kastrati A, Dirschinger J, Pache J, Seyfarth M, Blasini R, et al. Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA 2002; 287:210-215.
26. Heer T, Schiele R, Schneider S, Gitt AK, Wienbergen H, Gottwik M, et al. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol 2002; 89: 511-517.
27. Grazia Modena M. Acute myocardial infarction-are women different? Int J Clin Pract 2005; 59: 2-5.
28. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008; 29: 932-940.
29. Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 2002; 105: 297-303.
30. Valgimigli M, Campo G, Percoco G, Bolognese L, Vassanelli C, Colangelo S, et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA 2008; 299: 1788-1799.
31. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1524 women after myocardial infarction. Comparison with 4315 men. Circulation 1991; 83: 484-491.
32. Chandra NC, Ziegelstein RC, Rogers WJ, Tiefenbrunn AJ, Gore JM, French WJ, et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med 1998; 158: 981-988.
33. Liu Y, Wang LF, Yang XF, Ge YG, Wang HG, Xu L, et al. Gender differences in efficacy of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Chin Med J 2008; 121: 2374-2378.
34. MacIntyre K, Stewart S, Capewell S, Chalmers JW, Pell JP, Boyd J, et al. Gender and survival: a population-based study of 201 114 men and women following a first acute myocardial infarction. J Am Coll Cardiol 2001; 38: 729-735.
35. Healy B. The Yentl syndrome. N Engl J Med 1991; 325:274-276.
36. Hollenbeak CS, Weisman CS, Rossi M, Ettinger SM. Gender disparities in percutaneous coronary interventions for acute myocardial infarction in Pennsylvania. Med Care 2006; 44:24-30.
37. Zhang Q, Zhang RY, Qiu JP, Zhang JF, Wang XL, Jiang L, et al. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. Chin Med J 2008; 121: 485-491.
38. Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, et al. Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years. Chin Med J 2006; 119: 1151-1156.
39. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
40. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007; 297:2001-2009.
41. Brener SJ, Moliterno DJ, Aylward PE, van't Hof AW, Ruzyllo W, O'Neill WW, et al. Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study. Eur Heart J 2008; 29: 1127-1135.
42. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007; 28: 1709-1716.
43. Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, et al. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med 2008; 168: 485-491.
44. Koek HL, de Bruin A, Gast F, Gevers E, Kardaun JW, Reitsma JB, et al. Short- and long-term prognosis after acute myocardial infarction in men versus women. Am J Cardiol 2006; 98: 993-999.